NusaPure
St. John's Wort 1100 mg
Serving
2 Veggie Capsule(s)
Per container
90
Form
capsule-unknown
UPC
X001MROHBJ
DSLD
Formula hash
2b4bf6710851
Brand context
Catalog
265
products
With avoid flag
1
products
FDA recalls
0
history
CAERS
2
reports
Clean labelObjective label signals
Flagged excipients
0
none
FDA recalls
0
no recall history
CAERS reports
2
FDA consumer events
Certifications
0
none recorded
No authority-flagged excipients or recalls. · Every flag below links to the authority's published citation.
NIH LiverTox
1 ingredient with hepatotoxicity classification
Worst severity: Category D
- St. John's WortCategory D
LiverTox Category D. Few case reports of hepatitis; causality uncertain. Major drug-interaction concern (CYP3A4 induction) — can reduce levels of warfarin, oral contraceptives, immunosuppressants, HIV antivirals.
LiverTox →
Supplement Facts
2 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| St. John's Wort extract St. John's WortherbUNII · UFH8805FKA LiverTox D | 650 mg | — |
| St. John’s Wort powder St. John's WortherbUNII · UFH8805FKA LiverTox D | 450 mg | — |
FDA CAERS · adverse event context
2
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Cellulose · Silica · Magnesium Stearate · Rice Flour